A critical function for type I interferons in cancer immunoediting - PubMed (original) (raw)
doi: 10.1038/ni1213. Epub 2005 Jun 12.
Affiliations
- PMID: 15951814
- DOI: 10.1038/ni1213
A critical function for type I interferons in cancer immunoediting
Gavin P Dunn et al. Nat Immunol. 2005 Jul.
Erratum in
- Nat Immunol. 2005 Aug;6(8):852
Abstract
'Cancer immunoediting' is a process wherein the immune system protects hosts against tumor development and facilitates outgrowth of tumors with reduced immunogenicity. Although interferon-gamma (IFN-gamma) is known to be involved in this process, the involvement of type I interferons (IFN-alpha/beta) has not been elucidated. We now show that, like IFN-gamma, endogenously produced IFN-alpha/beta was required for the prevention of the growth of primary carcinogen-induced and transplantable tumors. Although tumor cells are important IFN-gamma targets, they are not functionally relevant sites of the actions of the type I interferons. Instead, host hematopoietic cells are critical IFN-alpha/beta targets during development of protective antitumor responses. Therefore, type I interferons are important components of the cancer immunoediting process and function in a way that does not completely overlap the functions of IFN-gamma.
Comment in
- Type I interferon and cancer immunoediting.
Smyth MJ. Smyth MJ. Nat Immunol. 2005 Jul;6(7):646-8. doi: 10.1038/ni0705-646. Nat Immunol. 2005. PMID: 15970935 No abstract available.
Similar articles
- Type I interferon and cancer immunoediting.
Smyth MJ. Smyth MJ. Nat Immunol. 2005 Jul;6(7):646-8. doi: 10.1038/ni0705-646. Nat Immunol. 2005. PMID: 15970935 No abstract available. - A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice.
Liu WJ, Wang XJ, Clark DC, Lobigs M, Hall RA, Khromykh AA. Liu WJ, et al. J Virol. 2006 Mar;80(5):2396-404. doi: 10.1128/JVI.80.5.2396-2404.2006. J Virol. 2006. PMID: 16474146 Free PMC article. - Adaptive immunity maintains occult cancer in an equilibrium state.
Koebel CM, Vermi W, Swann JB, Zerafa N, Rodig SJ, Old LJ, Smyth MJ, Schreiber RD. Koebel CM, et al. Nature. 2007 Dec 6;450(7171):903-7. doi: 10.1038/nature06309. Epub 2007 Nov 18. Nature. 2007. PMID: 18026089 - Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.
Zhang SY, Boisson-Dupuis S, Chapgier A, Yang K, Bustamante J, Puel A, Picard C, Abel L, Jouanguy E, Casanova JL. Zhang SY, et al. Immunol Rev. 2008 Dec;226:29-40. doi: 10.1111/j.1600-065X.2008.00698.x. Immunol Rev. 2008. PMID: 19161414 Review. - Interferons, interferon-like cytokines, and their receptors.
Pestka S, Krause CD, Walter MR. Pestka S, et al. Immunol Rev. 2004 Dec;202:8-32. doi: 10.1111/j.0105-2896.2004.00204.x. Immunol Rev. 2004. PMID: 15546383 Review.
Cited by
- Immune status and combined immunotherapy progression in Kirsten rat sarcoma viral oncogene homolog (KRAS)-mutant tumors.
He D, Bai R, Chen N, Cui J. He D, et al. Chin J Cancer Res. 2024 Aug 30;36(4):421-441. doi: 10.21147/j.issn.1000-9604.2024.04.06. Chin J Cancer Res. 2024. PMID: 39246706 Free PMC article. - Nature of the Association between Rheumatoid Arthritis and Cervical Cancer and Its Potential Therapeutic Implications.
Gusakov K, Kalinkovich A, Ashkenazi S, Livshits G. Gusakov K, et al. Nutrients. 2024 Aug 5;16(15):2569. doi: 10.3390/nu16152569. Nutrients. 2024. PMID: 39125448 Free PMC article. Review. - The Role of IRF9 Upregulation in Modulating Sensitivity to Olaparib and Platinum-Based Chemotherapies in Breast Cancer.
Choi S, Bae HG, Jo DG, Kim WY. Choi S, et al. Genes (Basel). 2024 Jul 22;15(7):959. doi: 10.3390/genes15070959. Genes (Basel). 2024. PMID: 39062738 Free PMC article. - Targeting chromosomal instability in patients with cancer.
Al-Rawi DH, Lettera E, Li J, DiBona M, Bakhoum SF. Al-Rawi DH, et al. Nat Rev Clin Oncol. 2024 Sep;21(9):645-659. doi: 10.1038/s41571-024-00923-w. Epub 2024 Jul 11. Nat Rev Clin Oncol. 2024. PMID: 38992122 Review. - Intratumoral NKT cell accumulation promotes antitumor immunity in pancreatic cancer.
Li J, Moresco P, Fearon DT. Li J, et al. Proc Natl Acad Sci U S A. 2024 Jul 16;121(29):e2403917121. doi: 10.1073/pnas.2403917121. Epub 2024 Jul 9. Proc Natl Acad Sci U S A. 2024. PMID: 38980903 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases